Skip to main content
. Author manuscript; available in PMC: 2007 Sep 25.
Published in final edited form as: Med Sci Sports Exerc. 2004 Jul;36(7). doi: 10.1249/01.MSS.0000132270.43579.1A

TABLE 4.

Individual and group regression coefficients and variance explained in knee laxity by changes in estradiol, progesterone, and testosterone across the menstrual cycle.

Regression Coefficients with Constant (*P < 0.01)
Subject R2 Const E P T E*P E*T P*T E*P*T
6 63.53% 2.38 1.42E−02* 4.47E−01* 2.25E−02* −4.03E−03* −2.78E−04* −9.09E−03* 8.41E−05*
8 62.76% 5.56 −9.83E−02* −2.22E+00 −8.94E−03 9.08E−02* 1.42E−03* 2.11E−02 −1.41E−03*
9 66.28% −2.95 6.27E−02* 1.76E+00* 1.26E−01* −1.26E−02* −1.04E−03* −3.08E−02* 2.17E−04*
14 68.89% 3.00 1.39E−02* −7.81E−01* −1.06E−02 4.80E−03 −6.13E−04* 1.76E−02* −9.86E−05
15 66.89% 11.91 −6.32E−02* −1.74E+00* −1.14E−01* 1.59E−02* 1.24E−03* 2.49E−02* −2.43E−04*
16 66.51% 5.94 −8.48E−02* −5.04E+00* −1.09E−01* 1.07E−01* 3.12E−03* 1.67E−01* −3.43E−03*
17 72.35% −0.30 4.92E−02* 3.38E+00* 1.78E−01* −2.46E−02* −1.46E−03* −1.40E−01* 8.70E−04*
19 78.09% 5.11 −6.08E−03 1.59E+00* −2.92E−02 −1.76E−02* 3.56E−04 −2.81E−02* 3.54E−04*
20 60.44% 10.89 −3.62E−02* −4.01E−01* −1.22E−01* 4.83E−03* 1.05E−03* 7.79E−03* −1.08E−04*
21 50.51% 0.64 4.22E−02* 2.70E−01 3.57E−02 −5.05E−03* −7.89E−04* 3.00E−03 6.79E−05
23 59.70% 2.30 1.87E−02* 1.27E+00* 8.58E−02* −5.97E−03* −3.39E−04* −2.34E−02* 1.11E−04*
25 69.76% 3.24 3.66E−02* 2.88E+00* 5.48E−02* −3.42E−02* −7.91E−04* −5.95E−02* 7.14E−04*
26 59.03% 3.95 8.86E−03* −1.97E−01* −3.32E−02* 2.97E−04 −8.80E−06 5.82E−03* −1.14E−05
27 48.64% −0.22 5.58E−02* 8.57E−01* 1.20E−01* −8.32E−03* −1.26E−03* −2.33E−02* 2.07E−04*
29 57.28% −0.80 4.71E−02* 2.01E−01 1.77E−01* 3.10E−03 −9.49E−04* −1.78E−03 −1.25E−04
30 69.41% 2.42 1.36E−02* −1.46E+00* 6.45E−02* 8.97E−03* −4.19E−04* 4.68E−02 −3.08E−04
33 72.68% 2.36 2.42E−02* 2.06E+00* 1.13E−01* −1.67E−02* −1.06E−03* −7.11E−02* 6.14E−04*
34 65.83% 24.08 −2.05E−01* −5.72E+00* −6.44E−01* 5.50E−02* 6.40E−03* 1.88E−01* −1.84E−03*
35 58.77% 14.67 −1.00E−01* −3.59E+00* −1.39E−01* 4.64E−02* 1.79E−03* 5.57E−02 −7.07E−04*
36 55.17% 15.54 −1.17E−01* −2.62E+00* −3.47E−01* 3.07E−02* 4.03E−03* 1.18E−01* −1.41E−03*
37 51.12% 13.32 −2.34E−02* 7.51E−01* −9.06E−02* −1.41E−02* 3.70E−04 −1.62E−02* 3.13E−04*
38 68.93% 5.41 2.01E−02* 4.87E−01* 7.87E−02* −3.89E−03* −7.00E−04* −3.22E−02* 2.23E−04*
Mean 63.30% 2.94 9.10E−03 2.21E−01 4.42E−02 5.75E−03 −2.11E−04 −7.79E−03 −1.27E−04
Group 7.60% 0.01 4.19E−03* −1.28E−02* 9.35E−03* −5.80E−05 8.84E−05* −2.39E−04 −3.44E−05*

E, estradiol; P, progesterone; T, testosterone.

*

Significant contribution to the model, P < 0.01.